AI assistant
NextTrip, Inc. — Director's Dealing 2022
Aug 12, 2022
34837_dirs_2022-08-11_d88c154f-d953-4c66-8991-f3612109e4aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGMA LABS, INC. (SASI)
CIK: 0000788611
Period of Report: 2022-08-09
Reporting Person: Beckett Darren (CTO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-09 | Stock Option (right to buy) | $2.50 | A | 15849 | Acquired | 2027-07-01 | Common Stock (15849) | Direct |
Footnotes
F1: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on August 9, 2022.
F2: The stock option vests as follows: (i) 3,962 shares subject to the option vested on the date of grant, and (ii) the remaining 11,887 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.